Dr. Yu Chung Tsang is a consultant in pharmacokinetics, biopharmaceutics and biostatistics, with specialty in the areas of PK bioequivalence and clinical endpoint study design and data analysis/interpretation. He obtained his Bachelor’s degree in Pharmacy in 1984 and PhD degree in Pharmacokinetics in 1990 from the University of Toronto. He holds an appointment (status only) at the Leslie Dan Faculty of Pharmacy and is one of the lecturers for the graduate course PHM 1133 Advanced Pharmacokinetics.
Prior to starting his consulting business, Dr Tsang worked for Apotex Inc. for over 33 years, with his last position being the Chief Scientific Officer, Biopharmaceutics and Biostatistics. His main responsibilities were to provide pharmacokinetic and statistical advice in preparing protocol and study reports for pharmacokinetic/pharmacodynamic and clinical studies of complex drug and biosimilar products, and in the design of bioequivalence/clinical endpoint studies and the analysis of data for the development of traditional generic drug products in the Apotex group of companies. In his career, he was involved with the design and data analysis of over one thousand bioequivalence/clinical studies for the registration of complex drug and biosimilar products and over 300 traditional generic drugs in Canada, US, EU, and many other international marketplaces. He also provided statistical support in clinical trials of new chemical entities at ApoPharma.